Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1984 1
1997 2
1998 1
1999 4
2000 4
2001 4
2002 3
2003 8
2004 16
2005 17
2006 20
2007 27
2008 33
2009 49
2010 51
2011 50
2012 66
2013 73
2014 102
2015 126
2016 136
2017 160
2018 167
2019 194
2020 177
2021 212
2022 91
Text availability
Article attribute
Article type
Publication date

Search Results

1,574 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Kozikis
Page 1
Guillain-Barré Syndrome Associated with SARS-CoV-2.
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G. Toscano G, et al. N Engl J Med. 2020 Jun 25;382(26):2574-2576. doi: 10.1056/NEJMc2009191. Epub 2020 Apr 17. N Engl J Med. 2020. PMID: 32302082 Free PMC article. No abstract available.
POMC Neurons: From Birth to Death.
Toda C, Santoro A, Kim JD, Diano S. Toda C, et al. Annu Rev Physiol. 2017 Feb 10;79:209-236. doi: 10.1146/annurev-physiol-022516-034110. Annu Rev Physiol. 2017. PMID: 28192062 Free PMC article. Review.
Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial.
Davies A, Merli F, Mihaljević B, Mercadal S, Siritanaratkul N, Solal-Céligny P, Boehnke A, Berge C, Genevray M, Zharkov A, Dixon M, Brewster M, Barrett M, MacDonald D. Davies A, et al. Lancet Haematol. 2017 Jun;4(6):e272-e282. doi: 10.1016/S2352-3026(17)30078-9. Epub 2017 May 2. Lancet Haematol. 2017. PMID: 28476440 Clinical Trial.
We aimed to show the pharmacokinetic non-inferiority of subcutaneous rituximab to intravenous rituximab in follicular lymphoma and to provide efficacy and safety data. METHODS: SABRINA is a two-stage, randomised, open-label phase 3 study at 113 centres in 30 countries. ...
We aimed to show the pharmacokinetic non-inferiority of subcutaneous rituximab to intravenous rituximab in follicular lymphoma and to provid …
Hypothalamic glucose-sensing mechanisms.
Yoon NA, Diano S. Yoon NA, et al. Diabetologia. 2021 May;64(5):985-993. doi: 10.1007/s00125-021-05395-6. Epub 2021 Feb 5. Diabetologia. 2021. PMID: 33544170 Free PMC article. Review.
Conversation with Sabrina Moerkl, MD, PhD.
Maddox M. Maddox M. Integr Med (Encinitas). 2021 Dec;20(6):18-22. Integr Med (Encinitas). 2021. PMID: 35250399 No abstract available.
1,574 results